We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKT icon
4876
PUT
Rocket Companies
RKT
$38.8B
$13.2K ﹤0.01%
679
-445,921
-100% -$7.78M
DUOT icon
4877
Duos Technologies
DUOT
$235M
$13.1K ﹤0.01%
+1,786
New +$12.7K
PHGE icon
4878
BiomX
PHGE
$1.97M
$13.1K ﹤0.01%
1,316
AUTL
4879
Autolus Therapeutics
AUTL
$389M
$12.8K ﹤0.01%
7,883
-7,917
-50% -$15.5K
PRT
4880
PermRock Royalty Trust Unit
PRT
$26.8M
$12.8K ﹤0.01%
3,221
DWX icon
4881
State Street SPDR S&P International Dividend ETF
DWX
$529M
$12.8K ﹤0.01%
300
PRLD icon
4882
Prelude Therapeutics
PRLD
$375M
$12.5K ﹤0.01%
8,712
+110
+1% +$110
FIRY
4883
Firy Inc
FIRY
$154M
$12.5K ﹤0.01%
+1,564
New +$12K
AC
4884
DELISTED
Associated Capital Group
AC
$12.5K ﹤0.01%
372
+120
+48% +$4.33K
FBRX icon
4885
Forte Biosciences
FBRX
$1.57B
$12.3K ﹤0.01%
+820
New +$9.45K
LMTL
4886
Direxion Daily LMT Bull 2X ETF
LMTL
$10.3M
$11.8K ﹤0.01%
+350
New +$10K
MREO
4887
CALL
Mereo BioPharma
MREO
$48.9M
$11.5K ﹤0.01%
+5,600
New +$10.3K
WEC icon
4888
CALL
WEC Energy
WEC
$36.3B
$11.5K ﹤0.01%
+100
New +$10.8K
ERO icon
4889
Ero Copper
ERO
$2.64B
$11.3K ﹤0.01%
559
-39,086
-99% -$595K
ADUR
4890
Aduro Clean Technologies
ADUR
$449M
$11.3K ﹤0.01%
843
AEP icon
4891
CALL
American Electric Power
AEP
$70.4B
$11.3K ﹤0.01%
+100
New +$10.9K
EWG icon
4892
iShares MSCI Germany ETF
EWG
$1.56B
$11.1K ﹤0.01%
266
-212
-44% -$8.88K
ULBI icon
4893
Ultralife
ULBI
$88.3M
$10.8K ﹤0.01%
1,582
+1,580
+79,000% +$12K
CEE
4894
Central and Eastern Europe Fund
CEE
$137M
$10.8K ﹤0.01%
700
VLTO icon
4895
CALL
Veralto
VLTO
$24.1B
$10.7K ﹤0.01%
+100
New +$10.6K
JOF
4896
Japan Smaller Capitalization Fund
JOF
$316M
$10.5K ﹤0.01%
1,000
ASBPW
4897
Aspire Biopharma Warrant
ASBPW
$447K
$10.5K ﹤0.01%
350,000
IXHL icon
4898
Incannex Healthcare
IXHL
$34.8M
$10.4K ﹤0.01%
750
MBAVU
4899
DELISTED
M3-Brigade Acquisition V Corp Units
MBAVU
$10.3K ﹤0.01%
1,005
-1,305
-56% -$16.1K
CHCI icon
4900
Comstock Holding Companies
CHCI
$152M
$10K ﹤0.01%
+714
New +$10.2K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.